COVID-19-induced liver injury in infants, children, and adolescents

Rana Bitar1,2, Ahmed A Elghoudi3,4, David Rawat1,2

  • 1Division of Pediatric Gastroenterology, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.

Insights

COVID-19 in children often causes mild illness, but liver injury can occur. Pre-existing liver conditions increase the risk of severe COVID-19 outcomes.

Area of Science:

  • Pediatrics
  • Hepatology
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) commonly presents with respiratory symptoms in children, though gastrointestinal and liver manifestations are also observed.
  • While most pediatric COVID-19 cases are mild, a subset requires advanced medical care, with liver injury being a notable complication.

Purpose of the Study:

  • To review liver manifestations in pediatric COVID-19 patients.
  • To detail the epidemiology, mechanisms, clinical presentation, management, and prognosis of liver injury in children with and without pre-existing liver disease, including those with prior liver transplants.

Main Methods:

  • This study is a review of existing literature on pediatric COVID-19 and liver manifestations.
  • The review synthesizes information on viral invasion, immune responses, and medication effects contributing to liver injury.

Main Results:

  • Liver dysfunction in children with COVID-19 can range from mild to severe, influenced by pre-existing liver conditions like non-alcoholic fatty liver disease.
  • Liver manifestations are linked to COVID-19 severity and serve as an independent prognostic factor.
  • Children with pre-existing liver disease face a higher risk of severe COVID-19 and adverse outcomes.

Conclusions:

  • Supportive therapies are crucial for managing COVID-19 in children, with vaccination recommended for high-risk individuals.
  • Understanding liver injury mechanisms and prognostic factors is vital for optimizing care and outcomes in pediatric COVID-19 patients.
  • The presence of liver disease significantly impacts COVID-19 prognosis in children, necessitating tailored management strategies.

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
692
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
998
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
227
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
44